Feed aggregator

Textron Inc. (TXT): Mario Gabelli Has a Long-Term Bet on This Stock

Top Stories - Sun, 04/12/2026 - 16:21

AMETEK Inc. (AME): Mario Gabelli Is Betting Big on This Stock

Top Stories - Sun, 04/12/2026 - 16:20

Sony Group Corporation (SONY): Mario Gabelli Remains Bullish on This Stock

Top Stories - Sun, 04/12/2026 - 16:19

The Bank of New York Mellon Corporation (BK): Mario Gabelli Admires This Banking Stock

Top Stories - Sun, 04/12/2026 - 16:19

Truist Maintains Buy Rating on SmartStop Self Storage REIT (SMA)

Top Stories - Sun, 04/12/2026 - 16:18

StubHub Holdings (STUB) Partners with vivenu to Expand Ticket Distribution

Top Stories - Sun, 04/12/2026 - 16:18

EquipmentShare (EQPT): The Best Buy-Rated All-Time Low Stock to Buy

Top Stories - Sun, 04/12/2026 - 16:18

Piper Sandler Maintains Overweight Rating on Blue Owl Capital (OWL)

Top Stories - Sun, 04/12/2026 - 16:18

Erste Group Downgrades Toyota Motor (TM) to Hold

Top Stories - Sun, 04/12/2026 - 16:18

BofA Lowers its Price Target on Pfizer (PFE) to $26 from $27

Top Stories - Sun, 04/12/2026 - 16:18

Here is why Devon Energy (DVN) is Among the Best Cheap Large Cap Stocks to Buy Now

Top Stories - Sun, 04/12/2026 - 16:18

Wells Fargo Maintains Overweight Rating on Synchrony (SYF)

Top Stories - Sun, 04/12/2026 - 16:18

UBS Raises its Price Target on MetLife (MET) to $102

Top Stories - Sun, 04/12/2026 - 16:18

Cantor Fitzgerald Maintains Overweight Rating on Hartford Insurance (HIG)

Top Stories - Sun, 04/12/2026 - 16:18

BofA Raises its Price Target on Teva Pharmaceutical (TEVA) to $42

Top Stories - Sun, 04/12/2026 - 16:18

Delta Air Lines (DAL): The Best Cheap Large Cap Stock to Buy Now

Top Stories - Sun, 04/12/2026 - 16:18

Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05)

Top Stories - Sun, 04/12/2026 - 16:18

RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE)

Top Stories - Sun, 04/12/2026 - 16:18

Here is why Biohaven (BHVN) is Among the Top Healthcare Stocks Insiders Are Buying

Top Stories - Sun, 04/12/2026 - 16:18

H.C. Wainwright Raises its Price Target on Aktis Oncology (AKTS) to $33

Top Stories - Sun, 04/12/2026 - 16:18
Syndicate content
 
Worldstockexchange® Information Center